AYURVEDIC MANAGEMENT OF DUCHENNE MUSCULAR DYSTROPHY by Mudadla, *Suryanarayana & Injamuri, Radhika
AYUSHDHARA              ISSN: 2393-9583 (P)/ 2393-9591 (O) 
 An International Journal of Research in AYUSH and Allied Systems 
AYUSHDHARA | May-June 2015 | Vol 2 | Issue 3  188 
       
   
     
  
AYURVEDIC MANAGEMENT OF DUCHENNE MUSCULAR DYSTROPHY 
Suryanarayana Mudadla1*, Radhika Injamuri2 
*1Assistant Professor, P.G Dept. of Kaumarabhritya, SJGAMC&H Research Centre, Koppal, Karnataka, 
India.  
2M.D. Scholar, Dept. of Kaumarabhritya, S.V.Ayurvedic College, Tirupati, Andhra Pradesh, India.  
 
Article info 
Article History: 
Received: 14-07-2015 
Accepted: 05-08-2015 
KEYWORDS: DMD, Dystrophin, 
Beeja dushti, Abhyanga, Sastika Sali 
pinda sweda, Vasti. 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT  
DMD is one among the most common muscular disorders. The incidence 
is 1:3600 live born infant boys worldwide. It is X-linked recessive 
disease caused by a deficiency of a normal muscle protein called 
dystrophin, which maintains the integrity of the muscle cell wall. 
Eventually irreversible progressive muscle weakness and degeneration 
of the skeletal or voluntary muscles, which control movement leading to 
lose the ability to stand, walk and loss of ambulation before 10years, 
with progression of the disease, most patients succumb to death in their 
early 20s. As there is no specific treatment in any system of medicine 
and the disease prognosis is unpreventable but if we start treatment in 
early stages of ambulant DMD boys, it may slow or stop the progressive 
degeneration of muscles. DMD cannot be directly co-related with any 
single disease in Ayurveda. All most all major neuromuscular disorders 
are identified with Vata dosha. In Ayurveda this pathogenesis can be 
clearly understood by the concept of Adhi bala pravritta vyadhi. Here the 
pathogenesis occurs due to the Beeja bhagavayava dusti which leads to 
Mamsa vata dushti. The present study was under taken to increase 
functional and physical capabilities, minimizing disability to delay 
further progression of disease and to maintain the ambulation for longer 
time and to improve quality in the activities of daily living. 30 children 
with DMD were taken up for the study of age between 05-16years and 
were given treatment for 2 weeks consisting of Abhyanga with Bala taila, 
shastika shali Pinda swedana followed by Vasti. The study has been 
subjected to statistical analysis, in which the results were found to be 
encouraging. 
INTRODUCTION 
Among the more than 20 different genetic 
muscular disorders, the most common fatal one is 
DMD. It is ubiquitous and it occurs all around the 
world, causing considerable hardships to affected 
individuals and their families.DMD is x-linked recessive 
disease caused by a deficiency of normal muscle 
protein called dystrophin which maintains the integrity 
of the muscle cell wall. This leads to progressive muscle 
weakness and exhibits the symptoms like difficulty in 
getting up from floor, difficulty in walking, climbing 
stairs, frequent falls while walk and finally loss of 
ambulation1. The term dystrophy means “abnormal 
growth” or “faulty nourishment” or “poor nourishment” 
was popularised at the close of the 19th century, 
derived from Greek word “trophe” meaning 
nourishment. The incidence is 1:3600 live born infant 
boys. The abnormal dystrophin gene on Xp21.1 locus 
and is one of the largest mammalian gene. In affected 
families which the mother is known to be a carrier of 
the gene, 50% of boys will be affected, and 50% of the 
girls will be carriers. Despite the X-linked recessive 
inheritance in DMD, about 30% of cases are new 
mutations and the mother is not a carrier. The new 
mutation rate in the dystrophin gene is high. Most 
cases are born now in families with no prior history of 
the disease. Patho physiology in brief, Dystrophin is a 
large, rod shaped cytoskeletal protein (molecular wt: 
427000 Daltons) transcribed from a 14000 base mRNA, 
that is encoded by 79exons within the enormous 
2.4million base DMD gene located at Xp21.2. Although 
dystrophin accounts for only 0.002% of total muscle 
protein, its absence reduction or abnormality and 
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changes in its associated membrane proteins appear to 
be the primary lesion in a no. of related myopathic or 
dystrophic disorders, resulting in variable phenotype of 
muscle wasting2. Clinical presentation, Early gross 
motor skills such as rolling over, sitting, standing are 
usually achieved at the appropriate ages or may mildly 
delayed, Around 2-3 years of age, boys with DMD may 
appear to be “somewhat clumsy” due to hip girdle 
weakness. By the age of 3-5years they often have 
difficulty keeping with their peers on the play ground. 
In some children they can never run in their life. 
Toddlers might assume a lordotic posture when 
standing to compensate for gluteal weakness. An early 
“Gower’s sign” is often evident by age 3years and it is 
fully expressed by age of 5 or 6 years, delayed walking, 
frequent falls while walk, trouble in running, difficulty 
in climbing upstairs, toe walking, pseudo hypertrophy 
of calves, relentlessly progressive weakness of muscles, 
leading to wheel chair confinement at 12years. Death 
occurs usually at about 18-20years of age3. The cause 
of death are respiratory failure in sleep, intractable 
heart failure, pneumonia occasionally aspiration and 
airway obstruction. 
This disease cannot be directly co-related with 
any single disease in Ayurveda. All most all major 
neuro muscular disorders are identified with Vata 
dosha. This disorder can be considered under Vata 
vikara due to Bheeja dusti because of Adibalapravritta4. 
The cardinal symptoms is ‘Chestahani’ which indicates 
a decrease in the Chala guna and Pravarthaka chestana 
of Vayu. Finally causes paraplegia and Sarvanga vata. 
The important causative factors can be 
brought under Aatma karmaja and beeja dosha5. These 
factors bring Khavaigunya at Mamsa dhatu levels 
leading to vitiation of Vata which causes Bhutagni 
impairment6. Thus these two causes attribute to DMD 
may be analysed as Bheeja dusti and Atma karma are 
responsible for the X-linked recessive disease as well as 
gene mutations.  
SAMPRAPTHI can be sort out as it is result of 
Mamsa-vata-kshaya due to Bheeja dosha which leads to 
Vata Vaishamya of Mamsa dhatu. This vitiated Vayu 
causes improper formation of Mamsa dhatu by its 
influence on the Dhatvagni of Mamsa7. So depletion of 
Mamsagni causes formation of Ama which leads to 
faulty nutrition and causes progressive relentless 
degeneration of muscle tissue8. Considering DMD as 
Vata vikara, Vasti treatment is adopted, as this best 
treatment for diseases of Vata. The treatment modality 
is applied mainly to combat 
Vata dosha along with drugs having Balya, 
Rasayana, Agni vardhaka & Vatahara properties. Any 
Shodana procedure should always be preceded by 
Snehana and Swedana.  
a) ABHYANGAM 9–Bala taila. 
b) PINDA SWEDAM10 – Shali dhanya (Rakta), 
Balamoola kwath, Milk, cloth and 2 vessels. 
c) VASTI11– Madhu, saindavam, Shatapuspa, Tailam 
(Bala tail), Gomutram, Kashaya – prepared with 
Balamoola, Dasamoola, Yasti, Raasna quath churna  
d)  Instruments for Vasti – 50ml disposable 
syringe, Nel’s catheter 16 size. 
Table 1: Method of Preparation and Administration of Vasti 
Ingredients 05 – 10yrs (150ml) 11– 16 yrs (200ml) 
Madhu 4 ml 6ml 
Saindavam ½ g 2g 
Satapushpa 1 g 2g 
Kashayam 
4 g   
2 g 66ml  80ml  
1 g   
Tailam – Bala Taila 75 ml 100ml 
Gomutram  5 ml 10ml  
The above mentioned quantity of drugs is measured 
based on total dosage required for the particular age 
group.  
Method of preparation of Vasti 
Step 1: Madhu is first taken in the Khalwa and then 
Saindavam is added. They are mixed uniformly till the 
sticky sound disappears. 
Step 2: Tailam is added till the mixture becomes 
homogenous. 
Step 3: Shatapushpa is added, mixed carefully. 
Step 4: Kwatha prepared using above mentioned drugs 
in the ratio 1:8 and reduce to ¼ quantity, appropriate 
amount is added to Vasti preparation. 
Step 5: Gomutram was added slowly & mixed 
uniformly.  
Step 6: Vasti dravya was made lukewarm by keeping it 
in hot water. 
Method of Administration 
● The child was given very light food neither too 
Snigdha nor too Ruksha. It was checked that the 
child has passed the stool routinely in the 
morning. As Abhyangam with Bala taila and Pinda 
swedana has been done, after these Purvakarma 
the patient was made to lie in left lateral position 
with left lower extremity straight and right lower 
extremity flexed on knee and hip joint on the Vasti 
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table. Then the anal orifice was smeared with oil 
for lubrication. 
● Required quantity of Vasti dravya was taken as 
per age and then was taken into syringe 
connected to Catheter (Nel’s catheter – 16 size). 
Then the Catheter was smeared with oil and after 
removing air bubbles the Catheter was introduced 
into rectum for about 4 inches and then Vasti 
dravya was gently pushed inside. 
● During administration of Vasti, the child was 
made to take deep breath through his mouth. 
● After the procedure the child was made to lie 
down on supine posture after gently tapping his 
buttocks. Then the child was made to lie down 
and mother/ attendant were advised to notice the 
time of retention. 
● The same procedure is done for 11 days. The 
patients were advised to take usual food. 
 The review of follow up is done & asked to come for 
next sitting with gap of 2 months 
Clinical Plan 
Patients were selected from OPD /IPD of S.V. 
Ayurvedic hospital in department of Kaumarabhritya, 
based on the inclusion criteria and clinical symptoms. 
Inclusion Criteria 
a. Patients between the age group 5 – 16 yrs. 
b. Children having mild to moderate physical 
disability  
c. Children with DMD. 
 Exclusion Criteria 
a. children with advanced stage of DMD with 
cardio myopathies, respiratory complications 
b. Congenital muscular dystrophies 
c. Myelopathies 
d. Congenital myopathies 
e. Metabolic muscle diseases 
f. Becker’muscular dystrophy 
Diagnosis: already diagnosed cases were taken and 
also repeated serum creatine kinase muscle 
enzyme,which is sensitive indication of active muscular 
dystrophy. 
Study design 
All the patients were given Vasti for 11 days. 
All were subjected to Abhyangam with Bala taila and 
Pinda swedana with Rakta shali as per classical method 
prior to Vasti therapy for 14 days. During this period 
oral medication is also given which is continued 
between the sittings also 
Table 2: Treatment plan 
Group Treatment Dose Duration 
05– 10 Yrs Abhyangam with Bala taila (20 – 25minutes) 
Pinda swedam (10 – 25 minutes) 
Vasti 
30 – 40 ml 
 
150ml 
14 days 
14 days 
11 days 
11– 16 Yrs Abhyangam with Bala taila (20 – 30 minutes) 
Pinda swedam (20 – 35 minutes) 
Vasti 
40 – 50 ml 
 
200ml 
14 days 
14 days 
11 days 
Table 3: Assessment criteria 
Criteria 3- severe 2- Moderate 1- Mild 0- No complaint 
Symptoms 
Falling down while 
walk 
>5 times /day 1-5 times/day 1-5 times/week ceased 
Difficulty in walking Difficulty in 
walking even 
small distance 
Difficulty in 
walking long 
distance with stops 
Difficulty in walking 
long distances 
without stops 
Able to walk 
without difficulty 
Difficulty in 
climbing stairs 
With assistance With support Without support Without support 
& difficulty 
Muscle power in the 
upper limbs 
G1 G2 G3 G4 
Toe walking continuous often occasional absent 
2) Barthel Index:12 
Grooming 
0- Needs help with personal care 
1- Independent 
face/hair/teeth/shaving/brushing 
 
 
Feeding 
0- Unable 
1- Needs help cutting/spreading butter, etc 
2- Independent 
Toilet use 
0- Dependent 
1- Needs some help, but can do something alone 
2- Independent (on and off, dressing, wiping) 
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Bathing 
0- Dependent 
1- Independent 
Dressing 
0- Dependent 
1- Needs help (but can do about half unaided) 
2- Independent (including buttons, zips, laces) 
      Stairs 
0- Unable  
1- Needs help (verbal/physical/carrying aid) 
2- Independent  
Transfer 
0- Unable- no sitting balance 
1- Major help (one or two people, can sit) 
2- Minor help (verbal or physical) 
3- Independent 
Mobility 
0- Immobile 
1- Wheel chair independent 
2- Walks with help of one person 
3- Independent (but may use any aid) 
The efficacy of therapy was studied on various 
parameters and the results were derived after 
subjecting to statistical methodology by using Student 
paired t-test. 
Results
Table 4: The effects of the therapy on various parameters were as follows 
S. No Characteristics No. of 
Observations 
Mean Score SD P Remarks 
BT AT 
1 Falling down while walk 27 2.5 0.4 0.9595 <0.001 Highly Significant 
2 Difficulty in walking 28 2.3 1.4333 0.7761 <0.001 Highly Significant 
3 Difficulty in climbing 
stairs 
26 2.1 1.3 0.6644 <0.01 Highly Significant 
4 Muscle power in the 
upper limbs 
30 2.4667 0.8667 0.7701 <0.001 Highly Significant 
5 Toe walking 27 2.4667 1.1 0.7112 <0.001 Highly Significant 
Improvement in the ADL 
Improvement in the ADL was assessed by Barthel index which is useful for measuring the functional status 
of the individual. In this score total possible score ranges from 0 to 20. If used to measure improvement after 
treatment, changes of more than two points in the total score reflects a probable genuine change and is also likely to 
be reliable. After treatment 04 points improved in two cases, 03 points improvement in 14 cases, 02 points 
improved in 10 cases, one point improved in two cases while remaining 02 cases were unchanged. 
The overall change in the total score is 2.6 which denote genuine change after the treatment.  
Table 5: Percentage of overall improvement in each ailment after treatment in 30 patients with respect to 
assessment criteria 
Ailment Percentage improvement 
Falling down while walk 84% 
Difficulty in walking 37.68% 
Difficulty in climbing stairs 38.09% 
Muscle power in the upper limbs 64.86% 
Toe walking 54.05% 
 
At
BT0
1
2
3
Falling 
down while 
walk
Difficulty in 
walking
Difficulty in 
climbing 
stairs
Muscle 
power in 
the upper 
limbs
Toe walking
At
BT
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DISCUSSION 
By this treatment encouraging progress 
observed in the following major complaints Frequent 
falls while walk completely ceased in 18patients, good 
progress in 6cases, while remaining 3 children got 
moderate results. Overall 84% of progress is observed 
may be due to increased muscle power in the both 
lower limbs and softening of the pseudo hypertrophy of 
calves. After treatment there was good result in 15 
patients with improvement in quality of walking, in 
7patients there is moderate improvement and in 
6patients no improvement. 
Overall percentage of progress is 37.68% 
Difficulty in climbing stairs in 09 there was moderate 
progress and no improvement in 07 patients.  
Overall percentage of progress is 38.09%. It was 
statistically highly significant.  
Muscle power in the upper limbs: There was an 
overall progress of 64.86%. Among 27 cases there is 
excellent improvement in 03 cases, 24 cases got good 
improvement, while remaining 03 cases got moderate 
improvement. After treatment most of the patients 
were able to raise both hands by overcoming the 
gravity due to improved muscle power. 
In Toe walking there was excellent result in 
one case with complete correction of toe walking. In 14 
cases there was good improvement, moderate results 
in 08 cases and remaining 04 patients had no 
improvement. This result is due to reduction of 
spasticity in the Achilles tendons and by lengthening of 
already contracted connective tissue. And there may be 
reduced hyper tonus in calves, increased muscle power. 
Overall progress was 54.05%. 
The overall change in the total score of Barthel index is 
2.6 
Effect of therapies on other ailments 
Contractures 
Most often involve the Ankles, Knees, Hips and 
elbows, because the muscle fibers shorten and fibrosis 
occurs in connective tissue. Among 30 one child had 
contractures at knees. He got good result with 
improvement in the extension of knees (increased 
range of motion).  
Pseudo hypertrophy of calves 
As per the observations all young ambulant 
boys had the complaint of pseudo hypertrophy of 
calves with hard consistency. After treatment there was 
marked change in consistency i.e. calves become soft 
and size is also reduced in all the cases of DMD. 
Frequent falls and toe walking has come down due to 
decreased tonicity in the calves.  
Gower’s sign 
An early Gower’s sign is often evident by age 3 
years and is fully expressed by age 5 or 6 years. This is 
a clinical assessment of pelvic muscle weakness in 
which considerable result was not observed and 
Gower’s sign is remained persisted.  
All these results were obtained by Abhyanga, 
Pindasweda and Vasti. Their mode of action presumed 
to be as follows.  
Abhyanga stimulates circulatory system, 
enhancing cell activity, increases blood flow, 
vasodilatation result in nourishment of the muscles, 
strengthening the muscles, releasing facial 
constrictions, assisting in reducing connective tissue 
thickening and provide flexibility by decreasing fibrous 
adhesions from muscle tissue injury. Due to Abhyanga 
progress is seen in reduction of toe walking, relieving 
contractures, nourishment of atrophied muscles, 
increasing muscle power and assisting muscle tone.13 
Heating the skin has been demonstrated to 
produce a decrease in gamma activity. With a decrease 
in gamma activity, the stretch on the muscle spindle 
would be less, thus reducing afferent firing from the 
spindle. This indirect method ultimately results in 
decreased alpha motor neuron firing and thus less 
muscle spasm. Elevating muscle temperature can also 
alter strength and endurance. Heating can result in 
decreased joint stiffness and increased tissue 
extensibility, thus facilitating ease of motion and gains 
in range of movements14.  
Vasti is having two actions, expelling the Dosa 
& nourishing the body as it is indicated in 
Gambhiragata vata also15. First, potency of the Vasti 
drugs gets absorbed to have its systemic action. Its 
second major action is related with the facilitation of 
excretion of morbid substances responsible for the 
disease process into the colon, from where they are 
evacuated. 
CONCLUSION 
The present study was under taken to increase 
functional and physical capabilities, minimizing 
disability to delay further progression of disease and to 
maintain the ambulation for longer time and to 
improve quality in the activities of daily living. 
30 children with DMD were taken up for the 
study of age between 05-16years and were given 
treatment for 2 weeks consisting of Abhyanga with 
Bala taila, Shastika shali Pinda swedana followed by 
Balamooladi Vasti which was continued even during 
the interval period of 2 months. 
Based on the observations and results it is 
concluded that 
 The given treatment is efficacious. 
 Frequent fall down while walk was stopped in 
many patients, while it was reduced in some other 
patients. Overall 84% of progress is observed.  
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 Considerable improvement in difficulty (37.68%) 
in walking and climbing stairs (38.09%) was 
observed. 
 The muscle power in the upper limbs improved 
(64.86%) significantly which was expressed by 
raising hands above the shoulder without 
difficulty. 
 Toe (54.05%) walking also shown considerable 
reduction.  
 Contractures also released to some extent. 
There is overall progress observed 
functionally, physically, psychologically, and 
nutritionally in these children with minimum or no side 
effects, which is much economical. 
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